Skip to main content

Dr. David E. Moll, MD

Heart Failure & Transplant Cardiology (Advanced Heart Failure and Transplant Cardiology Physician)

7777 Hennessy Blvd, Suite 1000
Baton Rouge, LA 70808

Who else practices at this address →

East Baton Rouge Parish includes primary care (46% of residents) shortage areas. About shortage areas

Call (225) 767-3900

  • Medicare participating

At a glance

Years since graduation
18
In the NPI registry since
2008
Medicare patients seen, 2024
907

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Advanced Heart Failure and Transplant Cardiology Physician primary
    LA license 203702
  • Cardiovascular Disease Physician
    LA license MD.203702
  • Student in an Organized Health Care Education/Training Program

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Heart Failure & Transplant Cardiology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
907
Services billed
2,531
Patients’ average age
74
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 30-39 minutes539339
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report457326
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only287263
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function245235
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes11651
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes6460
New patient office or other outpatient visit, 45-59 minutes6060
Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days3817
Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report1717
Ultrasound of heart blood flow, valves and chambers1515

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 18 companies reported 66 payments worth $20,788 in total to this clinician.

By type
Compensation for services other than consulting (speaking, faculty)$16,008
Travel and Lodging$3,312
Food and Beverage$1,343
Education$126

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Apr 21, 2025Actelion Pharmaceuticals US, Inc.
Apr 21, 2025
Compensation for services other than consulting (speaking, faculty)
UPTRAVI; OPSUMIT · Cardiology
$2,940
Mar 20, 2025Actelion Pharmaceuticals US, Inc.
Mar 20, 2025
Compensation for services other than consulting (speaking, faculty)
UPTRAVI; OPSUMIT · Cardiology
$2,940
May 28, 2025Actelion Pharmaceuticals US, Inc.
May 28, 2025
Compensation for services other than consulting (speaking, faculty)
UPTRAVI; OPSUMIT · Cardiology
$2,520
May 5, 2025Actelion Pharmaceuticals US, Inc.
May 5, 2025
Compensation for services other than consulting (speaking, faculty)
UPTRAVI; OPSUMIT · Cardiology
$2,520
Feb 4, 2025Actelion Pharmaceuticals US, Inc.
Feb 4, 2025
Compensation for services other than consulting (speaking, faculty)
UPTRAVI; OPSUMIT · Cardiology
$2,520
Oct 29, 2025Bayer HealthCare Pharmaceuticals Inc.
Oct 29, 2025
Compensation for services other than consulting (speaking, faculty)
Adempas; Kerendia · Cardio-pulmonary
$1,413
Mar 18, 2025Actelion Pharmaceuticals US, Inc.
Mar 18, 2025
Travel and Lodging
UPTRAVI; OPSUMIT · Cardiology · travel to Mobile, AL · in-kind
$1,086
Mar 17, 2025Actelion Pharmaceuticals US, Inc.
Mar 17, 2025
Compensation for services other than consulting (speaking, faculty)
UPTRAVI; OPSUMIT · Cardiology
$840
Apr 18, 2025Actelion Pharmaceuticals US, Inc.
Apr 18, 2025
Travel and Lodging
UPTRAVI; OPSUMIT · Cardiology · travel to Houma, LA · in-kind
$832
May 23, 2025Actelion Pharmaceuticals US, Inc.
May 23, 2025
Travel and Lodging
UPTRAVI; OPSUMIT · Cardiology · travel to Thibodaux, LA · in-kind
$734
All 19 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Nov 12, 2025Actelion Pharmaceuticals US, Inc.
Nov 12, 2025
Education
OPSUMIT; UPTRAVI · Cardiology · in-kind
$99.99
Oct 29, 2025Bayer HealthCare Pharmaceuticals Inc.
Oct 29, 2025
Compensation for services other than consulting (speaking, faculty)
Adempas; Kerendia · Cardio-pulmonary
$1,413
Sep 5, 2025Merck Sharp & Dohme LLC
Sep 5, 2025
Education
WINREVAIR · CARDIOVASCULAR · in-kind
$25.70
Jul 30, 2025Actelion Pharmaceuticals US, Inc.
Jul 30, 2025
Compensation for services other than consulting (speaking, faculty)
UPTRAVI; OPSUMIT · Cardiology
$315
May 28, 2025Actelion Pharmaceuticals US, Inc.
May 28, 2025
Compensation for services other than consulting (speaking, faculty)
UPTRAVI; OPSUMIT · Cardiology
$2,520
May 23, 2025Actelion Pharmaceuticals US, Inc.
May 23, 2025
Travel and Lodging
UPTRAVI; OPSUMIT · Cardiology · travel to Thibodaux, LA · in-kind
$734
May 5, 2025Actelion Pharmaceuticals US, Inc.
May 5, 2025
Compensation for services other than consulting (speaking, faculty)
UPTRAVI; OPSUMIT · Cardiology
$2,520
May 1, 2025Actelion Pharmaceuticals US, Inc.
May 1, 2025
Travel and Lodging
UPTRAVI; OPSUMIT · Cardiology · travel to Hammond, LA · in-kind
$632
Apr 28, 2025Actelion Pharmaceuticals US, Inc.
Apr 28, 2025
Travel and Lodging
UPTRAVI; OPSUMIT · Cardiology · travel to Hammond, LA · in-kind
$5.50
Apr 28, 2025Actelion Pharmaceuticals US, Inc.
Apr 28, 2025
Travel and Lodging
UPTRAVI; OPSUMIT · Cardiology · travel to Thibodaux, LA · in-kind
$5.50
Apr 21, 2025Actelion Pharmaceuticals US, Inc.
Apr 21, 2025
Compensation for services other than consulting (speaking, faculty)
UPTRAVI; OPSUMIT · Cardiology
$2,940
Apr 18, 2025Actelion Pharmaceuticals US, Inc.
Apr 18, 2025
Travel and Lodging
UPTRAVI; OPSUMIT · Cardiology · travel to Houma, LA · in-kind
$832
Apr 2, 2025Actelion Pharmaceuticals US, Inc.
Apr 2, 2025
Travel and Lodging
UPTRAVI; OPSUMIT · Cardiology · travel to Hammond, LA · in-kind
$5.50
Mar 24, 2025Actelion Pharmaceuticals US, Inc.
Mar 24, 2025
Travel and Lodging
UPTRAVI; OPSUMIT · Cardiology · travel to Houma, LA · in-kind
$5.50
Mar 20, 2025Actelion Pharmaceuticals US, Inc.
Mar 20, 2025
Compensation for services other than consulting (speaking, faculty)
UPTRAVI; OPSUMIT · Cardiology
$2,940
Mar 18, 2025Actelion Pharmaceuticals US, Inc.
Mar 18, 2025
Travel and Lodging
UPTRAVI; OPSUMIT · Cardiology · travel to Mobile, AL · in-kind
$1,086
Mar 17, 2025Actelion Pharmaceuticals US, Inc.
Mar 17, 2025
Compensation for services other than consulting (speaking, faculty)
UPTRAVI; OPSUMIT · Cardiology
$840
Feb 21, 2025Actelion Pharmaceuticals US, Inc.
Feb 21, 2025
Travel and Lodging
UPTRAVI; OPSUMIT · Cardiology · travel to Mobile, AL · in-kind
$5.50
Feb 4, 2025Actelion Pharmaceuticals US, Inc.
Feb 4, 2025
Compensation for services other than consulting (speaking, faculty)
UPTRAVI; OPSUMIT · Cardiology
$2,520

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Louisiana →

Industry-funded research

Named as a principal investigator on 4 industry-funded studies in 2025, from 2 companies. The companies reported $52,950 in research payments for these studies, mostly to the institutions running them.

  • Finality Study #22618
    Bayer HealthCare Pharmaceuticals Inc.
  • REDEFINE-HF Study #22438
    Bayer HealthCare Pharmaceuticals Inc.
  • Confirmation Study #22563
    Bayer HealthCare Pharmaceuticals Inc.
  • ISM2502004A--Specimen Collection for the Evaluation of Alere NT-proBNP for Alinity i System in Outpatient Setting for Heart Failure (LANAIS-HF)
    Abbott Laboratories

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Sources

NPI registry (CMS NPPES, November 2026; record last updated April 28, 2021), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1780846717. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.